| Title: | Glycerate from intestinal fructose metabolism induces islet cell damage and glucose intolerance |
| Journal: | Cell Metabolism |
| Published: | 9 Jun 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35688154/ |
| DOI: | https://doi.org/10.1016/j.cmet.2022.05.007 |
| Citations: | 13 (11 in last 2 years) as of 8 Aug 2024 |
Publication 7372
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Dietary fructose, especially in the context of a high-fat western diet, has been linked to type 2 diabetes. Although the effect of fructose on liver metabolism has been extensively studied, a significant portion of the fructose is first metabolized in the small intestine. Here, we report that dietary fat enhances intestinal fructose metabolism, which releases glycerate into the blood. Chronic high systemic glycerate levels induce glucose intolerance by slowly damaging pancreatic islet cells and reducing islet sizes. Our findings provide a link between dietary fructose and diabetes that is modulated by dietary fat.16 Authors
- Yanru Wu
- Chi Wut Wong
- Eric N Chiles
- Allyson L Mellinger
- Hosung Bae
- Sunhee Jung
- Ted Peterson
- Jamie Wang
- Marcos Negrete
- Qiang Huang
- Lihua Wang
- Cholsoon Jang
- David C Muddiman
- Xiaoyang Su
- Ian Williamson
- Xiling Shen
1 Application
| Application ID | Title |
|---|---|
| 70726 | Association study of rare metabolic disorders and common metabolic syndromes |
Enabling scientific discoveries that improve human health